Lorlatinib in patients (Pts) with previously treated ALK(+) advanced non-small cell lung cancer (NSCLC): Updated efficacy and safety Meeting Abstract
| Authors: | Besse, B.; Solomon, B. J.; Felip, E.; Bauer, T. M.; Ou, S. H. I.; Soo, R. A.; Camidge, D. R.; Chiari, R.; Gadgeel, S. M.; Riely, G. J.; Tan, E. H.; Hayashi, H.; Mazieres, J.; Thurm, H. C.; Martini, J. F.; Abbattista, A.; Peltz, G.; Clancy, J. S.; Shaw, A. T. |
| Abstract Title: | Lorlatinib in patients (Pts) with previously treated ALK(+) advanced non-small cell lung cancer (NSCLC): Updated efficacy and safety |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 468s |
| Language: | English |
| ACCESSION: | WOS:000442916003206 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9032 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9032 -- Source: Wos |
